Skip to content
10-K

Annual Report

CYTOKINETICS INC CYTK

0001193125-26-076495

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 23, 2026 123.16M sh
Shares Diluted FY 2025 · Dec 31, 2025 120.1K sh
Shares Diluted FY 2025 · Dec 31, 2024 111.98K sh
Shares Diluted FY 2025 · Dec 31, 2023 96.52K sh
Capex FY 2025 · Dec 31, 2025 $24.81M
Capex FY 2025 · Dec 31, 2024 $3.91M
Capex FY 2025 · Dec 31, 2023 $1.42M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$510.01M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$395.89M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$414.33M
Long Term Debt FY 2025 · Dec 31, 2025 $246.38M
Long Term Debt FY 2025 · Dec 31, 2024 $93.23M
Short Term Debt FY 2025 · Dec 31, 2025 $41.18M
Short Term Debt FY 2025 · Dec 31, 2024 $11.52M
Cash And Equivalents FY 2025 · Dec 31, 2025 $122.52M
Cash And Equivalents FY 2025 · Dec 31, 2024 $94.86M
Stockholders Equity FY 2025 · Dec 31, 2025 −$659.63M
Stockholders Equity FY 2025 · Dec 31, 2024 −$135.37M
Stockholders Equity FY 2025 · Dec 31, 2023 −$386.32M
Stockholders Equity FY 2025 · Dec 31, 2022 −$107.9M
Current Liabilities FY 2025 · Dec 31, 2025 $202.45M
Current Liabilities FY 2025 · Dec 31, 2024 $179.67M
Total Liabilities FY 2025 · Dec 31, 2025 $2.08B
Total Liabilities FY 2025 · Dec 31, 2024 $1.54B
Current Assets FY 2025 · Dec 31, 2025 $916.98M
Current Assets FY 2025 · Dec 31, 2024 $1.11B
Total Assets FY 2025 · Dec 31, 2025 $1.42B
Total Assets FY 2025 · Dec 31, 2024 $1.4B
Eps Diluted FY 2025 · Dec 31, 2025 −$6.54
Eps Diluted FY 2025 · Dec 31, 2024 −$5.26
Eps Diluted FY 2025 · Dec 31, 2023 −$5.45
Eps Basic FY 2025 · Dec 31, 2025 −$6.54
Eps Basic FY 2025 · Dec 31, 2024 −$5.26
Eps Basic FY 2025 · Dec 31, 2023 −$5.45
Rd Expense FY 2025 · Dec 31, 2025 $416.03M
Rd Expense FY 2025 · Dec 31, 2024 $339.41M
Rd Expense FY 2025 · Dec 31, 2023 $330.12M
Net Income FY 2025 · Dec 31, 2025 −$784.96M
Net Income FY 2025 · Dec 31, 2024 −$589.53M
Net Income FY 2025 · Dec 31, 2023 −$526.24M
Operating Income FY 2025 · Dec 31, 2025 −$612.26M
Operating Income FY 2025 · Dec 31, 2024 −$536.25M
Operating Income FY 2025 · Dec 31, 2023 −$496.21M
Revenue FY 2025 · Dec 31, 2025 $88.04M
Revenue FY 2025 · Dec 31, 2024 $18.47M
Revenue FY 2025 · Dec 31, 2023 $7.53M